SEC Form 5 · accession 0000920465-19-000032
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 13, 2019 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | G | 17,742 | $0.00 | D | 1,266,704 | D | |
| Common Stock | Jun 8, 2018 | G | 900 | $0.00 | D | 1,265,804 | D | |
| Common Stock | Jun 8, 2018 | G | 900 | $0.00 | D | 1,264,904 | D | |
| Common Stock | Jun 8, 2018 | G | 900 | $0.00 | D | 1,264,004 | D | |
| Common Stock | Jun 8, 2018 | G | 900 | $0.00 | D | 1,263,104 | D | |
| Common Stock | holding | — | — | — | 22,000 | I | By children |
Table II — derivative securities
No Table II lines on this filing.